FDA Schedule A restricts the advertising of which type of treatments?

FDA Schedule A specifically restricts the advertising of treatments related to diseases and disorders. This regulation aims to ensure that the information provided to the public is accurate and not misleading, particularly when addressing serious health conditions. It prohibits advertising that may create a false sense of security or suggest guaranteed outcomes from treatments for conditions that can be complex or require a healthcare professional's guidance.

By focusing on diseases and disorders, the regulation seeks to protect the public from potentially harmful claims and to encourage individuals to seek proper medical advice rather than relying solely on advertisements for treatment solutions. This emphasizes the importance of professional oversight in managing health conditions rather than self-diagnosis or treatment based solely on promotional material.